What Is the APACHE II Scoring System?
The Acute Physiology and Chronic Health Evaluation II (APACHE II) is a validated severity-of-illness classification tool used to predict mortality in critically ill patients. It combines acute physiological derangements, chronic health status, and patient age into a single composite score.
The scoring system evaluates three domains:
- Patient characteristics: Age and significant comorbidities (organ insufficiency, immunocompromise)
- Acute physiological parameters: Temperature, blood pressure, heart rate, respiratory rate, oxygenation, and acid-base status
- Laboratory abnormalities: Electrolytes, renal function, blood counts, and pH
Higher APACHE II scores correlate directly with increased mortality risk. A score of 0–4 predicts approximately 4% mortality, whilst scores above 40 suggest mortality exceeding 80%. The score remains the reference standard for ICU severity assessment across teaching hospitals and research protocols.
APACHE II Score Calculation
The APACHE II score aggregates points from all three domains. Each physiological variable and comorbidity contributes a specific point allocation based on validated thresholds. The formula synthesizes age points, organ insufficiency status, surgical emergency status, and all acute physiological and laboratory derangements.
APACHE II Score = Age Points + Comorbidity Points + Surgery Points
+ Temperature Points + MAP Points + Heart Rate Points
+ Respiratory Rate Points + Oxygenation Points + pH Points
+ Sodium Points + Potassium Points + Creatinine Points
+ Hematocrit Points + WBC Points + (15 − Glasgow Coma Scale)
Age Points— 0–6 points based on age brackets; older patients accumulate higher scoresComorbidity Points— 5 points for non-operative or emergency surgery patients with severe organ disease; 2 points for elective postoperative patientsSurgery Points— 1 point if surgery was required in the 24 hours prior; 0 otherwiseTemperature, MAP, HR, RR, Oxygenation, pH— Each physiological variable earns 0–4 points depending on deviation from normal rangesElectrolytes & Renal Function— Sodium, potassium, and creatinine contribute 0–4 points each; acute renal failure multiplies creatinine weightHematocrit & WBC— Blood count abnormalities contribute 0–4 points eachGlasgow Coma Scale— Subtracts from 15; comatose patients (GCS 3) add 12 points
Key Considerations for Accurate APACHE II Scoring
Precise APACHE II scoring depends on meticulous data collection and correct interpretation of the point-allocation rules.
- Use worst values in the first 24 hours — APACHE II requires the single most abnormal value for each parameter during the initial 24-hour ICU stay, not the most recent measurement. A nadir temperature, lowest pH, or peak creatinine within that window must be recorded, even if the patient improves shortly after.
- Distinguish elective from emergency postoperative status — The comorbidity points differ significantly: emergency or non-operative patients with organ failure earn 5 points, whilst elective postoperative patients with the same comorbidity earn only 2 points. Misclassification directly distorts the final score and predicted mortality.
- Account for renal failure when scoring creatinine — Patients with acute or chronic renal failure have creatinine weighted differently—doubling the maximum points available. Confirm dialysis dependency or measured glomerular filtration rate before assigning creatinine points to avoid underestimating severity in renal patients.
- Glasgow Coma Scale requires accurate neurological examination — GCS assessment demands a calm, cooperative patient and experienced examiner. Sedation, intubation, or head trauma may confound scoring. Document the reason for any GCS component that cannot be assessed (e.g., intubated patients receive points only for eye opening and motor response).
Clinical Applications and Outcomes Benchmarking
APACHE II scores enable clinicians to stratify patients into mortality risk bands and guide intensity of care decisions. Hospitals track aggregate APACHE II cohorts to benchmark outcome data against regional and national standards, identifying quality gaps or exceptional performance.
The score facilitates:
- Prognostic counselling: Communicating realistic mortality estimates to families and patients
- Triage and resource allocation: Prioritizing invasive monitoring or organ support for highest-risk cohorts
- Research cohort matching: Ensuring comparable severity between control and intervention groups in clinical trials
- Quality assurance: Standardized severity adjustment allows meaningful comparison of mortality across ICU populations and institutions
Importantly, APACHE II predicts average population mortality; individual patient outcomes depend on unmeasured factors such as treatment quality, comorbidity severity, and physiological reserve.